World Lung Cancer Day
On this World Lung Cancer Day, Clinakos Inc. stands with the fighters and survivors rewriting the narrative of lung cancer. Lung cancer is a complex and often misunderstood disease, but with our Integrated Patient Data™ and Medically Smart AI™, we’re transforming how real-world insights drive personalized care and accelerate breakthroughs in oncology. By connecting diverse […]
The Predictive AI Surge in Healthcare
Per a recent report, the global AI for predictive healthcare market is experiencing rapid growth—rising from $8.85B in 2024 to $11.69B in 2025, and projected to reach nearly $48B by 2030. AI’s effectiveness is dependent on the quality of the data it is trained on. For AI tools used in healthcare, the quality, completeness, and […]
Mayo Clinic Natural History Study
The Mayo Clinic has launched a landmark natural history study focused on autosomal dominant leukodystrophy (ADLD), an ultra-rare hereditary neurodegenerative disorder. This initiative will collect deep, longitudinal data—medical records, imaging, genetics, and more—to better understand disease progression and accelerate new therapies for patients who urgently need them. At Clinakos Inc., we’re proud to support such […]
AI Discovery in Drug Discovery and Clinical Trials
AI is rapidly rewriting the rules for drug discovery and clinical trials. As highlighted in the latest Research and Markets report: By 2025, 30% of new drugs will be discovered using AI, a seismic shift from traditional methods. ⏳ AI-enabled workflows can cut the time to preclinical candidate selection by up to 40% and reduce […]
Cybersecurity and Data Privacy in Healthcare IT
As healthcare moves deeper into digital transformation, the stakes for data privacy and cybersecurity have never been higher. Organizations must evolve from compliance checklists to intelligent, proactive defense. At Clinakos, we’ve built security into the DNA of our platform—because real-world data only drives value when it’s trusted, protected, and private. Here’s how we power privacy-first […]
Brittany’s Bold Journey: Redefining Strength During Sarcoma & Bone Cancer Awareness Month
Brittany’s Bold Journey: Redefining Strength During Sarcoma & Bone Cancer Awareness Month This month, we amplify voices like Brittany C.’s, whose story reminds us that data is only part of the patient journey. At Clinakos Inc., we believe in the power of stories to inspire, inform, and drive better care. Meet Brittany: A Fighter Who […]
Sarcoma & Bone Cancer Awareness Month
July Is Sarcoma & Bone Cancer Awareness Month! Heard of sarcoma? Most people haven’t—and that’s exactly why we’re talking about it. At Clinakos Inc., we’re on a mission to bring rare cancers out of the shadows and into the spotlight. What’s a Sarcoma, Anyway? Imagine a cancer that can hide in your bones, muscles, or […]
Rare Should Not Mean Invisible
Rare diseases are costing us more than we think. 30 million Americans live with a rare disease. ⏳ It takes an average of 6 years and 17 medical encounters for diagnosis. And the cost? Over $1 trillion annually in the U.S. alone—just from 379 out of 10,000+ rare diseases. Here’s what’s even harder to process: […]
Graves’ Disease Awareness Month
Spotlight on Kade’s Courage This July, Clinakos Inc. is proud to honor Graves’ Disease Awareness Month by sharing Kade’s inspiring journey—a reminder that every child’s health story matters and that early action can change lives. Kade’s Story: Turning Uncertainty into Answers At just 4½, Kade’s endless energy and love for play were suddenly shadowed by […]
National Institutes of Health (NIH) announced a new funding opportunity for the Rare Diseases Clinical Research Consortia (RDCRC)
In May 2025, the National Institutes of Health (NIH) announced a new funding opportunity for the Rare Diseases Clinical Research Consortia (RDCRC), emphasizing collaborative, multi-site, and patient-centric non-interventional research. Read the news link below This initiative is a major step forward in rare disease research, focusing on: Collaboration across institutions and disciplines Multi-site studies to […]
